BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15844076)

  • 1. Interpreting vaccine efficacy.
    Greenwood B
    Clin Infect Dis; 2005 May; 40(10):1519-20. PubMed ID: 15844076
    [No Abstract]   [Full Text] [Related]  

  • 2. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine and ongoing lessons.
    Shinefield H
    Int J Clin Pract Suppl; 2001 Feb; (118):23-5. PubMed ID: 11715361
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of invasive pneumococcal disease after introduction of the Universal Infant Immunization Program, British Columbia (2002-2005).
    Can Commun Dis Rep; 2006 Jul; 32(14):157-61. PubMed ID: 16869067
    [No Abstract]   [Full Text] [Related]  

  • 5. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
    Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief review of the clinical effectiveness of PREVENAR against otitis media.
    Fletcher MA; Fritzell B
    Vaccine; 2007 Mar; 25(13):2507-12. PubMed ID: 17011085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
    Abzug MJ; Pelton SI
    J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS
    Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
    Moore MR; Whitney CG
    Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
    Bjornson G; Scheifele DW; Bettinger J; Patrick DM; Gustafson L; Daly P; Tyrrell GJ
    Pediatr Infect Dis J; 2007 Jun; 26(6):540-2. PubMed ID: 17529875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for a hospital-based pneumococcal vaccine trial for HIV-seropositive South Africans.
    Smego RA; Genovese G; Klugman KP
    Int J Infect Dis; 2000; 4(4):231-2. PubMed ID: 11231189
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under usage of conjugate pneumococcal vaccine in the Irish neonatal population.
    Breatnach C; McMahon P
    Ir Med J; 2007 Jan; 100(1):345. PubMed ID: 17380930
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.
    Temime L; Boelle PY; Opatowski L; Guillemot D
    PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conjugate vaccines changed the epidemiology of infection].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2006 Aug; 29(8):307-8. PubMed ID: 16927601
    [No Abstract]   [Full Text] [Related]  

  • 19. Pneumococcal vaccines in India.
    Dutta AK; Aggarwal A
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S39-43. PubMed ID: 11411384
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.
    Bridy-Pappas AE; Margolis MB; Center KJ; Isaacman DJ
    Pharmacotherapy; 2005 Sep; 25(9):1193-212. PubMed ID: 16164394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.